Jupiter Debt To Equity from 2010 to 2024
| JUNS Stock | USD 11.88 0.93 8.49% |
Debt To Equity | First Reported 2010-12-31 | Previous Quarter (0.37) | Current Value (0.39) | Quarterly Volatility 0.08281959 |
Check Jupiter Neurosciences, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jupiter Neurosciences,'s main balance sheet or income statement drivers, such as Interest Expense of 298.9 K, Selling General Administrative of 2.8 M or Total Revenue of 199.5 K, as well as many indicators such as Price To Sales Ratio of 533, Dividend Yield of 0.0 or Days Sales Outstanding of 32.73. Jupiter financial statements analysis is a perfect complement when working with Jupiter Neurosciences, Valuation or Volatility modules.
Jupiter | Debt To Equity |
Latest Jupiter Neurosciences,'s Debt To Equity Growth Pattern
Below is the plot of the Debt To Equity of Jupiter Neurosciences, Common over the last few years. It is a measure of a company's financial leverage calculated by dividing its total liabilities by stockholders' equity, indicating the proportion of equity and debt the company is using to finance its assets. Jupiter Neurosciences,'s Debt To Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jupiter Neurosciences,'s overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.00 % | 10 Years Trend |
|
Debt To Equity |
| Timeline |
Jupiter Debt To Equity Regression Statistics
| Arithmetic Mean | (0.24) | |
| Coefficient Of Variation | (34.85) | |
| Mean Deviation | 0.04 | |
| Median | (0.24) | |
| Standard Deviation | 0.08 | |
| Sample Variance | 0.01 | |
| Range | 0.3608 | |
| R-Value | (0.14) | |
| Mean Square Error | 0.01 | |
| R-Squared | 0.02 | |
| Significance | 0.63 | |
| Slope | (0) | |
| Total Sum of Squares | 0.1 |
Jupiter Debt To Equity History
About Jupiter Neurosciences, Financial Statements
Jupiter Neurosciences, shareholders use historical fundamental indicators, such as Debt To Equity, to determine how well the company is positioned to perform in the future. Although Jupiter Neurosciences, investors may analyze each financial statement separately, they are all interrelated. The changes in Jupiter Neurosciences,'s assets and liabilities, for example, are also reflected in the revenues and expenses on on Jupiter Neurosciences,'s income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Debt To Equity | (0.37) | (0.39) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Jupiter Stock Analysis
When running Jupiter Neurosciences,'s price analysis, check to measure Jupiter Neurosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jupiter Neurosciences, is operating at the current time. Most of Jupiter Neurosciences,'s value examination focuses on studying past and present price action to predict the probability of Jupiter Neurosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jupiter Neurosciences,'s price. Additionally, you may evaluate how the addition of Jupiter Neurosciences, to your portfolios can decrease your overall portfolio volatility.